National SAS Doctors' Event


Day 1


Day 2

Timings 25 March 12:45 to 16:00 and 26 March 9:45 to 13:45
Location Online
CPD Up to six hours subject to peer approval
Non Member Fee£100
SAS Fee£55
Consultant Fee£75
Book now
National SAS Doctors' Event

Event Information

This is an event aimed at SAS doctors to help support them in their current career and to help guide them in decision making regarding the options to become a Consultant.

The conference will run over two days with half a day focusing on academic content - “Treating Mental Health Disorders in a changing world”, and a further half focusing on non-academic content - “Developing and maintaining a high-quality portfolio for SAS doctors”

The objectives of this event are to provide relevant and up-to-date academic training as well as provide insight into non-academic areas of a SAS doctor's role (including leadership and influencing as a SAS doctor) and to provide a stimulus into decision-making regarding the options available to becoming a consultant.

This event is aimed specifically at SAS Doctors but it is also relevant for consultants who are mentoring and supporting SAS doctors, to help them understand the important role of a SAS doctor and the transition to a consultant.

The conference will run over a two-day period: 25-26 March 2021. 

ACADEMIC PROGRAMME 25 March 2021 - “Treating Mental Health Disorders in a changing world”


“Personality disorder management for the general Psychiatrist” Dr Steve Pearce -Consultant Psychiatrist and Programme Director, Oxfordshire and Buckinghamshire Complex Needs Service. 


Dr Steve Pearce has published and worked in the field of personality disorder for 15 years, and is head of the specialist community personality disorder service in Oxfordshire and Buckinghamshire. He is a past president of the British and Irish Group for the Study of Personality Disorder, and current chair of the RCPsych faculty of medical psychotherapy.  


It has been said that each generation of mental health professionals has to discover for itself the importance of personality disorder. Although personality disorder often seems elusive and to defy systematisation, the diagnosis appears to be indispensable’. Livesley 2001 

People with personality disorder pose some of the most difficult management and treatment challenges in psychiatry. In this talk Dr Pearce will outline some of the reasons for this, and how to effectively work with this group.  


“Anxiety Disorders” Professor David Baldwin - Professor of Psychiatry, Faculty of Medicine, University of Southampton 


David Baldwin is Professor of Psychiatry in the Clinical and Experimental Sciences Academic Unit of the Faculty of Medicine at the University of Southampton in the UK. He trained in medicine at Charing Cross Hospital Medical School, in psychiatry at St Mary's Hospital Medical School and the Maudsley Hospital, and in medical humanities at Birkbeck College. He is an Honorary Professor in the University of Cape Town in South Africa, and Visiting Professor at Shandong Mental Health Centre in Jinan, China. He is President-Elect of the British Association for Psychopharmacology, a Medical Patron of Anxiety UK, and Editor-in-Chief of Human Psychopharmacology. 


By the end of the talk, attendees will have refreshed their knowledge of the current evidence base regarding the efficacy and tolerability of pharmacological treatments for patients with anxiety disorders and anxiety-related disorders, and have extended their awareness of potential new targets in the development of potential anxiolytics, with examples based on immune mechanisms and acid-sensing ion channels. 

“Treatment resistant depression” 
Dr Mario Juruena - Clinical Senior Lecturer in Translational Psychiatry, King’s College London 


Dr Mario F P Juruena MD MSc Dip CBT MPhil PhD SARCPsych FBPsychA. Dr Juruena graduated in Medicine from Pontifical Catholic University, Southern Brazil. He completed his Psychiatry Training at the Porto Alegre Mental Health School and received his MPhil at the Federal University of Sao Paulo and then MSc Affective Neuroscience, at Maastricht University in the Netherlands. Dr Juruena received his PhD in Psychiatry at the University of London/King’s College London. Mario has also completed Specialisation in Cognitive Psychotherapy at Beck Institute, Philadelphia, USA. He is currently Senior Clinical Lecturer in Translational Psychiatry at the Institute of Psychiatry, Psychology and Neuroscience, Centre for Affective Disorders, Dept of Psychological Medicine at King’s College London. 

Dr Juruena is a Consultant Psychiatrist at South London and Maudsley Trust, currently the lead consultant for the Maudsley Advanced Treatment Service (MATS) for Treatment-Resistant Depression (TRD) and Bipolar, at South London and Maudsley NHS Foundation Trust (SLaM). Dr Juruena has published over 100 original research articles, reviews and book chapters, and edited five books. Most of his studies are related to the Neurobiology, Diagnosis and Treatment of Affective disorders; and their relationship to Stress. 

He was awarded by the British Association for Psychopharmacology ‘The Senior Clinical Psychopharmacology Award’ and also received the Robert W. Kerwin Psychopharmacology Prize from the Royal College of Psychiatrists for the best article published on the subject in the British Journal of Psychiatry. More recently, was awarded with the Newton Fellow from Royal Society and Academy of Medical Sciences. Dr Juruena is also an Adjunct Associate Professor at McGovern Medical School, University of Texas, Houston, USA 


Treatment-resistant depression (TRD) is a term used in clinical psychiatry to describe a condition that affects people with depression who do not respond adequately to a course of appropriate treatment within a specific time. The concepts of response, remission, recovery, and recurrence are categorical concepts borrowed from oncology, a field in which evidence of disease processes is more evident. Typical definitions of TRD vary; the inadequate response has traditionally been defined as no clinical response. However, many clinicians consider a response inadequate if the person does not achieve full remission of symptoms.  

The concept of TRD has additional limitations. First, TRD does not designate a biologically homogeneous group, and a clear line does not restrict it. Instead, when we define TRD by the number of failed treatment trials, the definition evolves as we acquire more pharmacologic, psychotherapeutic, neuromodulation and other treatments. Second, treatments that have failed likely define quite different groups. That is, depressions that fail with SSRI and those that fail with ECT are probably quite distinct.  

An alternative ‘difficult-to-treat depression’ model is presented and considered. It accepts that the treatment aims for some depressed patients may shift to optimal symptom control rather than remission. When difficult-to-treat depression is suspected, the many treatable causes of persistent depression must be assessed and addressed. The clinical and research implications of the difficult-to-treat depression model are discussed, then treatment may better focus on


NON-ACADEMIC PROGRAMME 26 March 2021 - “Developing and maintaining a high quality portfolio for SAS doctors” 

“CESR Application: An introduction on producing the perfect application” 
Professor Nandini Chakraborty - Consultant in early intervention in psychosis services in Leicester and an Hon Prof with the University of Leicester. Associate Dean of Equivalence in the Royal College of Psychiatrists 


Prof Nandini Chakraborty is a consultant in early intervention in psychosis services in Leicester and an Hon Prof with the University of Leicester. She is Associate Dean of Equivalence in the Royal College of Psychiatrists and works closely with the specialist registrations applications team of the GMC. 

She sits on the College education and training committee, quality revision committee and international advisory committees. She is currently member of the curriculum revision working group which has submitted new psychiatric curricula to GMC. She is a CASC examiner and external advisor of the College. Nandini is also a PLAB 2 examiner and member of the PLAB 1 panel.                       

As Associate Dean of equivalence, she bears responsibility for CESR dialogues with GMC and has been keenly interested in the recent changes to CESR-Combined pathways.  


Her presentation on CESR in psychiatry concentrates on the requirements of an application portfolio for CESR applicants in psychiatry and how supervisors, medical managers and organisations can support them in making successful CESR journeys. A psychiatry CESR portfolio is different from an ARCP one, not in the terms of work done in clinical or non-clinical areas but in the way the evidence is presented 


“Influencing/Leadership as a SAS doctor” 
Dr Mike Groves - Associate Specialist in Social and Rehabilitation Psychiatry and SAS Doctor Lead for Southern Health NHS Foundation Trust 


Dr Mike Groves is an Associate Specialist in Rehabilitation Psychiatry in Southampton. He provides medical leadership for both a CQC rated outstanding service and the Hampshire and Isle of Wight Sustainability and Transformation project in Rehabilitation and Reablement. He is SAS lead for Southern Health Foundation Trust and oversees both clinical and leadership development opportunities for his doctors. He is a member of the Royal College SAS doctor and South Eastern Division Executive committee. He has a passion for empowering SAS doctors to fulfil their potential. 


In light of the GMC survey of SAS and LED’s doctors in 2019, there remain ongoing challenges for SAS Doctors to access leadership opportunities. In this session we will explore ways to raise your profile and influence those around you in order to make your journey through the CESR process more enriching and allow you to shine when it comes to the consultant interview. 


“Your role in Clinical Governance” Professor Mike Crawford – Director of CCQI RCPsych 


Mike Crawford is Professor of Mental Health Research at Imperial College London and an Honorary Consultant Psychiatrist at Central and North West London NHS Foundation Trust. He is also the Director of the Royal College of Psychiatrists’ Centre for Quality Improvement where he oversees a programme of quality improvements initiatives including accreditation services and national audits 


Following results of a GMC survey in 2019 that found that 31% of SAS doctors had difficulty accessing CPD and only 11% had been involved in clinical governance, this interactive session will provide a short introduction to clinical governance and provide an opportunity to share the ways that people engage in these activities and factors that support effective involvement. 

  • The conference will take place online using Zoom.
  • Participants will be able to view a video of the speaker alongside any slides.
  • Participants can also pose questions, where the programme allows, and some speakers may use polling or other interactive features. 
  • All registered participants will have access to a recording for up to two months after the event.

For any further questions, please contact Karen Morgan.

This event is taking place online via Zoom. To take part you will need: 

  • access to a reliable internet connection
  • a PC, laptop, tablet or phone
  • Google Chrome or Microsoft Edge browser or Zoom installed on your PC, laptop, tablet or phone. 

To watch on demand you must register for the conference in advance.

  • Once the conference has taken place live, you will receive links to watch the conference/ sessions on demand.
  • To access the recordings you will be required to enter your name, email address and a password.
  • This is unique to you as a registered delegate so please do not share the recording links.  
  • All registered participants will have access to a recording for up to two months after the event. 

Please read our terms and conditions before making your booking.

Event Location

Location: Online